To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Breast Cancer: Screening
Thursday 24th October 2019

Asked by: Mary Creagh (Labour - Wakefield)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many women born in (a) 1965, (b) 1966, (c) 1967, (d) 1968 and (e) 1969 have (i) been invited for breast cancer screening and (ii) taken up an offer of breast cancer screening.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

In the Breast Screening Programme women are eligible to be screened from the age of 50 and are invited every three years. Data in the format requested is not available. The data below shows the number invited, uptake and coverage for the age bands 50-52 and 53-54 in 2017-2018.

The figures below are obtained from the 2017-18 Breast Screening Annual Report which can be viewed at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/breast-screening-programme/england-2017-18

Number invited (for ages 50-54) in 2017-18.


It should be noted that, women are invited every three years, so the number of invites in 2017-18 only represents approximately 1/3 of women in the 50-54 age band. Invite here refers to ‘first and all routine invitations’ – see report for detailed definitions.

Age Band

Indicator

Unit

Value

50-52

Invited

Number

435,678

53-54

Invited

Number

290,936

50-54

Invited

Number

726,614

Invites and uptake of those invites for women age 50-54, in England in 2017-18. (This is not the total number of women in the 50-54 age group, just the number invited in 2017-18).

Age Band

Indicator

Unit

Value

50-52

Invited

Number

435,678

50-52

Attended

Number

293,517

50-52

Uptake

%

67.4

53-54

Invited

Number

290,936

53-54

Attended

Number

200,131

53-54

Uptake

%

68.8

50-54

Invited

Number

726,614

50-54

Attended

Number

493,648

50-54

Uptake

%

67.9

Coverage of the breast screening programme for those aged 53-54 in England, as at 31 March 2018:

Number Resident

811,351

Number Eligible

809,841

Number Ineligible

1,510

Number never screened (either never invited or invited and did not attend)

157,385

Screened in last 3 years

587,955

Screening Coverage (%)

72.6%

It would not be suitable to provide coverage for the full 50-54 age group because the official coverage definition starts at age 53 (rather than age 50).


Written Question
NHS: Emergencies
Monday 9th September 2019

Asked by: Mary Creagh (Labour - Wakefield)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when the results of the deep dive of NHS organisations’ compliance against Emergency Preparedness, Resilience and Response will be published.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

It has not proved possible to respond to the hon. Member in the time available before Prorogation.


Written Question
Health Services: Standards
Monday 9th September 2019

Asked by: Mary Creagh (Labour - Wakefield)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what the timescale is for the Care Quality Commission quality framework to include temperature and hydration in the inspections as part of ensuring a safe environment.

Answered by Nadine Dorries

The Care Quality Commission already considers temperature and hydration as part of its inspection framework.


Written Question
Weather: Death
Monday 9th September 2019

Asked by: Mary Creagh (Labour - Wakefield)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate he has made of the (a) number and (b) nature of the excess deaths in the heatwave in June, July and August 2018.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

It has not proved possible to respond to the hon. Member in the time available before Prorogation.


Written Question
Radon Gas: Lung Cancer
Monday 9th September 2019

Asked by: Mary Creagh (Labour - Wakefield)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many (a) diagnoses of and (b) deaths from radon-related lung cancer there have been since 2010 in each Care Commissioning Group.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

It has not proved possible to respond to the hon. Member in the time available before Prorogation.


Written Question
Grenfell Tower: Fires
Thursday 5th September 2019

Asked by: Mary Creagh (Labour - Wakefield)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many casualties from the Grenfell Tower fire were transported to hospital.

Answered by Nadine Dorries

Following the Grenfell fire, enhanced health checks were introduced as a result of community concerns. The health checks are delivered though general practitioner practices and a community provider.

Since the health checks were established, 1,097 assessments have taken place (to July 2019). Of the 1,097 assessments that have taken place, 52 related to children and young people up to the age of 18. The remainder were adults. The precise age of those individuals assessed has not been collected at this stage but is something that will be considered going forward.

On Wednesday 14 June 2017, London Ambulance Service reported 68 casualties had been conveyed to hospitals from Grenfell Tower.

Additional National Health Service funding will provide up to £50 million over five years to support physical and mental health services as well as systematic health checks in the Grenfell area.


Written Question
Grenfell Tower: Fires
Thursday 5th September 2019

Asked by: Mary Creagh (Labour - Wakefield)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many people received health testing in the community as a result of the Grenfell Tower fire; and what the age was of people tested.

Answered by Nadine Dorries

Following the Grenfell fire, enhanced health checks were introduced as a result of community concerns. The health checks are delivered though general practitioner practices and a community provider.

Since the health checks were established, 1,097 assessments have taken place (to July 2019). Of the 1,097 assessments that have taken place, 52 related to children and young people up to the age of 18. The remainder were adults. The precise age of those individuals assessed has not been collected at this stage but is something that will be considered going forward.

On Wednesday 14 June 2017, London Ambulance Service reported 68 casualties had been conveyed to hospitals from Grenfell Tower.

Additional National Health Service funding will provide up to £50 million over five years to support physical and mental health services as well as systematic health checks in the Grenfell area.


Written Question
Health Services: Weather
Tuesday 3rd September 2019

Asked by: Mary Creagh (Labour - Wakefield)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the tenth special report of the Environmental Audit Committee, published on 24 October 2018 on Heatwaves: adapting to climate change: Government Response to the Committee's ninth report, HC 826, what plans he has in place to introduce a new single adverse weather and health plan and associated resources.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

Work to develop and introduce the Single Adverse Weather and Health Plan (SAWHP), and associated resources, is underway in line with the 2022 deadline set under the Second National Adaptation Programme (2018-2023).

Since October 2018, systematic literature reviews to update the evidence base have begun and behavioural insight research has been commissioned to support the development of effective and tailored public messages. Stakeholder workshops are set to be delivered across the country to ensure the SAWHP and its resources are developed in collaboration with end users. Public Health England and the Met Office are working together on the development of a year-round heat and cold alerting system, currently expected later this year.


Written Question
Diabetes: Medical Equipment
Friday 29th March 2019

Asked by: Mary Creagh (Labour - Wakefield)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans the Government and NHS England have to ensure that CCGs use the funding allocated nationally to prescribe Flash Glucose Monitoring from 1 April 2019 using central NHS criteria.

Answered by Caroline Dinenage

In November 2018, NHS England announced action to end the current variation in accessing flash glucose monitors. From April 2019 there will be a more consistent national approach to making these devices available. Clinical commissioning groups (CCGs) will be reimbursed to cover the costs of flash glucose monitoring sensors for those type 1 diabetes patients who are most likely to benefit from their use. NHS England has published detailed criteria and supporting guidance at the following link:

https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding.pdf

CCGs will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.

NHS England has engaged with NHS Clinical Commissioners, the membership organisation for CCGs, regarding the planned arrangements so that they can advise their members as appropriate. An FAQ for patients and commissioners is also being prepared and will be published, to aid the implementation. NHS England is also in conversations with the Academic Health Science Network to identify the capacity and scope for them to aid in rolling out flash glucose monitoring.

Due to the limitations of the data collected by the NHS Business Services Authority, it is not possible to conclusively state which CCGs do or do not currently prescribe flash glucose monitors.


Written Question
Diabetes: Medical Equipment
Friday 29th March 2019

Asked by: Mary Creagh (Labour - Wakefield)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps NHS England is taking to encourage CCGs which do not prescribe Flash Glucose Monitoring technology to do so as soon as possible when new guidance comes into effect from 1 April 2019.

Answered by Caroline Dinenage

In November 2018, NHS England announced action to end the current variation in accessing flash glucose monitors. From April 2019 there will be a more consistent national approach to making these devices available. Clinical commissioning groups (CCGs) will be reimbursed to cover the costs of flash glucose monitoring sensors for those type 1 diabetes patients who are most likely to benefit from their use. NHS England has published detailed criteria and supporting guidance at the following link:

https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding.pdf

CCGs will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.

NHS England has engaged with NHS Clinical Commissioners, the membership organisation for CCGs, regarding the planned arrangements so that they can advise their members as appropriate. An FAQ for patients and commissioners is also being prepared and will be published, to aid the implementation. NHS England is also in conversations with the Academic Health Science Network to identify the capacity and scope for them to aid in rolling out flash glucose monitoring.

Due to the limitations of the data collected by the NHS Business Services Authority, it is not possible to conclusively state which CCGs do or do not currently prescribe flash glucose monitors.